Neuland Laboratories Ltd has added 38.63% over last one month compared to 3.47% fall in S&P BSE Healthcare index and 3.16% rise in the SENSEX
Neuland Laboratories Ltd rose 8.97% today to trade at Rs 1515.4. The S&P BSE Healthcare index is up 1.07% to quote at 21288.72. The index is down 3.47 % over last one month. Among the other constituents of the index, Ajanta Pharma Ltd increased 4.87% and Suven Life Sciences Ltd added 3.85% on the day. The S&P BSE Healthcare index went up 53.29 % over last one year compared to the 21.85% surge in benchmark SENSEX.
Neuland Laboratories Ltd has added 38.63% over last one month compared to 3.47% fall in S&P BSE Healthcare index and 3.16% rise in the SENSEX. On the BSE, 2577 shares were traded in the counter so far compared with average daily volumes of 12371 shares in the past one month. The stock hit a record high of Rs 1525 on 03 Feb 2021. The stock hit a 52-week low of Rs 247.3 on 13 Mar 2020.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU